skip to main content
Opens in a new window
Opens an external site
Opens an external site in a new tab
When autocomplete results are available use up and down arrows to review and enter to select.
Close Search
About
Our Firm
Expertise
Patent Litigation
Patent Opinion
Trademark Litigation and Opposition
News
Awards
Diversity, Equity and Inclusion
Contact
Team
Marian Wolanski
Megan Pocalyuko
Andrew Medico
Mary Mutchler
Anna Hucman
Cases
IP Insights
Open search
Join us on LinkedIn
Contact
Open Main Site Navigation
Home
|
Sitemap
About
Our Firm
Expertise
Patent Litigation
Patent Opinion
Trademark Litigation and Opposition
News
Want to Join Belmore Neidrauer?
(5/14/2026 3:42:21 PM)
Marian Wolanski Recognized by Benchmark Litigation Canada 2026!
(5/1/2026 6:08:14 PM)
LEXPERT® recognizes Marian Wolanski!
(3/24/2026 8:35:51 PM)
Chambers Patent Litigation 2026
(3/3/2026 9:30:22 PM)
Belmore Neidrauer Recognized by Managing IP!
(2/11/2026 8:17:50 PM)
The 18th Annual Harold G. Fox Moot
(2/9/2026 5:00:00 AM)
Belmore Neidrauer Recognized by Chambers and Partners
(2/9/2026 5:00:00 AM)
Marian Wolanski will be speaking at the 14th Annual University of Toronto Patent Colloquium!
(11/13/2025 9:45:53 PM)
Belmore Neidrauer recognized by Best Law Firms™ – Canada
(10/30/2025 6:08:29 PM)
Pharmascience Inc. v Janssen Inc. (Supreme Court File No. 41209)
(10/16/2025 7:00:00 PM)
LMG Life Sciences Rankings 2025!
(10/16/2025 1:43:09 PM)
Belmore Neidrauer recognized in Chambers 2026
(10/16/2025 1:40:09 PM)
Belmore Neidrauer recognized in the 20ᵗʰ edition of Best Lawyers™
(10/16/2025 1:38:04 PM)
LMG Life Sciences Awards: Americas 2025
(9/5/2025 3:28:12 PM)
LMG Life Sciences recognizes Belmore Neidrauer
(9/5/2025 3:23:43 PM)
Belmore Neidrauer Shortlisted for 2025 LMG Life Sciences Americas Awards
(7/3/2025 6:18:29 PM)
Belmore Neidrauer Recognized by Managing IP!
(6/30/2025 6:19:06 PM)
Managing IP recognizes Marian Wolanski as a 2025 Patent Star!
(6/3/2025 8:31:41 PM)
IAM Patent 1000 recognizes Belmore Neidrauer!
(5/29/2025 10:27:30 PM)
Belmore Neidrauer Recognized by Benchmark Litigation Canada
(5/1/2025 4:40:07 PM)
Belmore Neidrauer Shortlisted for Managing IP Awards 2025
(2/28/2025 10:57:23 PM)
Peter Wilcox
(12/10/2024 7:10:08 PM)
Belmore Neidrauer Recognized by Best Law Firms™ - Canada
(10/31/2024 4:55:17 PM)
Peter Wilcox awarded the Peter W. McBurney Memorial Award for Professional Excellence
(10/1/2024 4:26:56 PM)
Chambers Canada Guide 2025 recognizes Belmore Neidrauer
(9/27/2024 1:14:39 PM)
Belmore Neidrauer Recognized by Best Lawyers in Canada™
(8/29/2024 2:51:24 PM)
Managing IP recognizes Partners as 2024 Patent Stars
(8/22/2024 3:37:26 PM)
Belmore Neidrauer Shortlisted for 2024 LMG Life Sciences Americas Awards
(7/19/2024 2:28:19 PM)
IAM Patent 1000 recognizes Belmore Neidrauer LLP
(6/5/2024 6:59:38 PM)
LEXPERT® recognizes Belmore Neidrauer as a Most Frequently Recommended Firm for Intellectual Property Litigation
(3/7/2024 4:16:44 AM)
Belmore Neidrauer Shortlisted for Managing IP Awards 2024
(2/27/2024 7:46:55 PM)
Belmore Neidrauer secured another victory in the Federal Court of Appeal for our client Janssen.
(2/16/2024 10:18:44 PM)
Belmore Neidrauer successfully represented Janssen on another appeal relating to infringement of Janssen’s patent covering INVEGA SUSTENNA®
(1/26/2024 9:53:01 PM)
Belmore Neidrauer successfully represented Janssen in the Federal Court of Appeal on another appeal relating to INVEGA SUSTENNA®
(1/24/2024 3:39:46 PM)
Belmore Neidrauer LLP Recognized by Legal 500 2024
(11/17/2023 4:46:20 PM)
Peter Wilcox recognized at the LMG Life Sciences Americas Awards
(9/8/2023 4:00:00 PM)
LMG Life Sciences recognizes Belmore Neidrauer
(9/8/2023 3:51:59 PM)
Peter Wilcox recognized in the Who’s Who Legal: IP 2023 Guide
(8/18/2023 3:49:00 PM)
Belmore Neidrauer Shortlisted for LMG Life Sciences Awards Americas 2023
(8/9/2023 1:54:58 PM)
IAM Patent 1000 recognizes Belmore Neidrauer LLP
(7/5/2023 8:58:24 PM)
Peter Wilcox recognized in Lexpert® Special Edition: Technology and Health 2023.
(7/4/2023 4:00:00 AM)
Managing IP recognizes Belmore Neidrauer Partners as 2023 Patent Stars
(6/9/2023 5:29:23 PM)
Benchmark Litigation Canada recognizes Belmore Neidrauer LLP
(5/9/2023 5:43:41 PM)
Marian Wolanski to speak at CBA IP Day 2023 in Ottawa
(4/24/2023 6:24:52 PM)
Peter Wilcox Shortlisted for Intellectual Property Litigator of the Year
(4/11/2023 3:35:00 PM)
Belmore Neidrauer successfully represented Janssen in the Federal Court of Appeal in a decision relating to Janssen's patent covering INVEGA SUSTENNA®
(4/11/2023 2:51:24 PM)
Lexpert recognizes Belmore Neidrauer as a Most Frequently Recommended firm for Intellectual Property Litigation
(3/1/2023 5:00:00 AM)
LMG Life Sciences recognizes Belmore Neidrauer
(10/5/2022 4:00:00 AM)
Belmore Neidrauer successfully represented Janssen in a patent trial affirming the validity of Janssen’s patent
(8/31/2022 4:00:00 AM)
Belmore Neidrauer Shortlisted for LMG Life Sciences Americas Awards 2022
(8/3/2022 4:00:00 AM)
IAM Patent 1000 recognizes Belmore Neidrauer
(7/4/2022 4:00:00 AM)
Managing IP recognizes Belmore Neidrauer Partners as 2022 Patent Stars
(6/16/2022 4:00:00 AM)
Lexpert recognizes Marian Wolanski and Peter Wilcox in 2022 Lexpert Special Edition: Technology and Health Sciences
(6/16/2022 4:00:00 AM)
LEXPERT® Recognizes Belmore Neidrauer as a leading Intellectual Property Litigation Firm
(2/10/2022 5:00:00 AM)
Belmore Neidrauer Recognized by Chambers Canada 2022 as a Leading Canadian Intellectual Property Litigation firm
(2/9/2022 5:00:00 AM)
Belmore Neidrauer successfully represented Janssen in two summary trials in the Federal Court
(2/9/2022 5:00:00 AM)
Peter Wilcox recognized as a Global Elite 2022 Thought Leader by Who’s Who Legal
(1/1/2022 5:00:00 AM)
Belmore Neidrauer recognized as one of Canada’s Best Law Firms 2022 by the Globe and Mail
(11/16/2021 5:00:00 AM)
Legal 500 Canada 2021 Rankings Recognize Belmore Neidrauer LLP
(11/12/2020 5:00:00 AM)
IP Stars 2020 Recognizes Belmore Neidrauer LLP
(10/16/2020 4:00:00 AM)
Belmore Neidrauer LLP Recognized by Chambers Canada 2021
(9/9/2020 4:00:00 AM)
Peter Wilcox Recognized by Best Lawyers in Canada 2020
(10/1/2019 4:00:00 AM)
Belmore Neidrauer Recognized at the LMG Life Sciences Awards 2019
(9/19/2019 4:00:00 AM)
Belmore Neidrauer Named Patent Contentious Firm of the Year - Canada 2019
(4/5/2019 4:00:00 AM)
Peter Wilcox recognized by Chambers Global 2019
(2/25/2019 5:00:00 AM)
Peter Wilcox recognized by Best Lawyers in Canada 2019
(12/12/2018 5:00:00 AM)
Peter Wilcox recognized as a leading lawyer in the 2019 Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada
(12/12/2018 5:00:00 AM)
IAM Patent 1000 Recognizes Belmore Neidrauer as a leading patent litigation firm
(9/20/2018 4:00:00 AM)
Peter Wilcox Invited to be Fellow of Litigation Counsel of America
(9/20/2018 4:00:00 AM)
Lexpert Recognizes Belmore Neidrauer as a Leading Firm in Litigation - Intellectual Property
(9/18/2018 4:00:00 AM)
Managing IP Recognizes Belmore Neidrauer in its IP Stars Firm Survey 2018
(9/18/2018 4:00:00 AM)
Marian Wolanski Awarded Canadian Rising Star of the Year at the 2018 LMG Life Sciences Awards
(9/18/2018 4:00:00 AM)
Peter Wilcox Recognized by Chambers Canada 2017 for Excellence in Intellectual Property Litigation
(10/11/2017 4:00:00 AM)
Belmore Neidrauer wins Canada Patent Contentious Firm of the Year and Case of the Year Awards
(3/27/2017 4:00:00 AM)
Peter Wilcox listed in WIPR Leaders Directory
(3/2/2017 5:00:00 AM)
New Belmore Neidrauer LLP Partner – Marian Wolanski
(2/1/2017 5:00:00 AM)
Peter Wilcox listed in the 2017 Lexpert American Lawyer Guide to the Leading 500 Lawyers in Canada
(1/20/2017 5:00:00 AM)
Peter Wilcox listed in the 2016 Lexpert US/Canada Cross-Border Guide - Litigation
(1/20/2017 5:00:00 AM)
Belmore Neidrauer wins Canadian Patent Contentious Firm of the Year at LMG Life Sciences Awards
(9/16/2016 4:00:00 AM)
Belmore Neidrauer LLP recognized in Managing Intellectual Property's IP Stars Handbook
(9/13/2016 4:00:00 AM)
LEXPERT® Recognizes Peter Wilcox
(6/24/2016 4:00:00 AM)
Belmore Neidrauer LLP Recognized Again by IAM Patent 1000: The World's Leading Patent Professionals 2016
(5/30/2016 4:00:00 AM)
Belmore Neidrauer LLP Ranked in Managing Intellectual Property Magazine
(3/7/2016 5:00:00 AM)
Chambers Canada recognizes Peter Wilcox in 2016
(1/4/2016 5:00:00 AM)
Peter Wilcox recognized by Best Lawyers in Canada 2016
(8/24/2015 4:00:00 AM)
Belmore Neidrauer LLP is listed in the Silver Band of 2015 edition of IAM Patent 1000
(6/30/2015 4:00:00 AM)
Peter Wilcox has been recognized by Who’s Who Legal 2015
(6/30/2015 4:00:00 AM)
Peter Wilcox is recognised by Chambers & Partners 2015
(5/7/2015 4:00:00 AM)
Benchmark Canada lists Belmore Neidrauer LLP as a "Recommended" Litigation Firm
(5/5/2015 4:00:00 AM)
Who's Who Legal Life Sciences recognizes Peter Wilcox
(12/22/2014 5:00:00 AM)
Awards
Diversity, Equity and Inclusion
Contact
Team
Anna Hucman
Andrew Medico
Mary Mutchler
Megan Pocalyuko
Marian Wolanski
Cases
Alexion Pharmaceuticals v Amgen Canada
Samsung Bioepis Co. Ltd. v Janssen Biotech, Inc.
Janssen Inc. v Apotex
Pharmascience v. Janssen
Janssen Inc. v JAMP
Janssen Inc. v Pharmascience Inc.
Janssen Inc. v Apotex Inc.
Janssen v. Pharmascience
Janssen Inc. v Apotex Inc.
Janssen Inc. et al v. Teva Canada Limited
Janssen v. Apotex
Janssen v. Apotex
Janssen v. Dr. Reddy
Janssen v. Pharmascience
Alexion v. Attorney General of Canada
Apotex Inc. v Janssen Inc. et al
Janssen v. Pharmascience
Janssen v Apotex
Janssen v Pharmascience
Janssen v Apotex, Pharmascience and Dr. Reddy’s Laboratories
Seedlings v. Pfizer
Eli Lilly Canada Inc. et al v. Apotex Inc.
Apotex v. Janssen
Elea v Simplot
Seedlings Life Sciences v Pfizer
Janssen Inc. et al v Teva Canada Limited
Janssen Inc. et al v Apotex Inc.
AbbVie Corporation et al v Samsung Bioepis Co. Ltd.
Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al.
Teva Canada Limited v. Janssen Inc.
Apotex Inc. v. Bayer Inc.
Janssen Inc. et al. v. Actavis Pharma Company et al.
Actavis Pharma Company v Alcon Canada Inc. et al
Bayer Inc. v. Apotex Inc. and Cobalt Pharmaceuticals Company
Pfizer Canada Inc. v. Teva Canada Limited
Bayer Inc. et al. v Fresenius Kabi Canada Ltd. et al.
Actavis Pharma Company v. Alcon Canada Inc.
Sanofi-Aventis Canada Inc. v. Eli Lilly Canada Inc.
Cobalt Pharmaceuticals Company v. Bayer Inc.
Takeda v. Apotex
Janssen Inc. v. Abbvie Corporation
Alcon Canada Inc. v. Cobalt Pharmaceuticals Company
Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Apotex Inc. and the Minister of Health
Teva Canada Limited v. Pfizer Canada Inc.
Alcon Canada Inc. v. Cobalt Pharmaceuticals Company - 2014 FC 149
Apotex Inc. v. Takeda Canada Inc.
Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Cobalt Pharmaceuticals Company and the Minister of Health
Varco Canada Limited v. Pason Systems Corp.
Alcon Canada Inc. v. Apotex Inc.
Janssen-Ortho Inc. v. Canada (Health)
Nicholas v. Environmental Systems (International) Limited
GlaxoSmithKline Inc. v. Pharmascience Inc.
Pfizer Canada Inc. v. Novopharm Limited
Pfizer Canada Inc. v. Apotex Inc.
Apotex Inc. v. Sanofi-Synthelabo Canada Inc.
Lotech Medical Systems Limited v. Kinetic Concepts Inc.
Pfizer Canada Inc. v. Canada (Health) - 2008 FCA 108
Pfizer Canada Inc. v. Canada (Health) - 2007 FC 649
Pfizer Canada Inc. v. Canada (Health) - 2007 FC 898
Pfizer Canada Inc. v. Canada (Minister of Health)
IP Insights
POP GOES THE TRADEMARK: POP MART SECURES TRADEMARK EXPUNGEMENT OF COMPETITOR MARK FOR NON-DISTINCTIVNESS, CONFUSION, AND BAD FAITH
(6/19/2026 4:00:00 AM)
Misuse of Copyright or Misuse of Court Resources: Federal Court Upholds CMJ Order Allowing Misuse of Copyright Defence and Barring Plaintiff’s Arguments Against Viability on the Grounds of Issue Estoppel and Abuse of Process
(6/12/2026 4:00:00 AM)
Too Little, Too Late: When A Letters Rogatory Motion Falls Short
(6/8/2026 4:00:00 AM)
Words Matter: The Battle Over the Exact Meaning of an Undertaking
(4/22/2026 3:30:23 PM)
WHEN THE CHIPS ARE DOWN: Federal Court of Appeal Dismisses McCain’s French Fry Process Patent Appeal
(4/14/2026 4:00:00 AM)
UNSUBSCRIBED: Federal Court of Appeal Overturns Lower Court’s Judgment Issuing Declarations in News Subscription Summary Judgment
(3/19/2026 4:00:00 AM)
WORKING (OUTSIDE) 9 TO 5: Employer’s Appeal in Respect of Copyright Ownership Dispute Dismissed
(3/19/2026 4:00:00 AM)
LOSING TRACTION: Truck Accessory Company’s Bid for Confidential Information Interlocutory Injunctions Rejected
(3/13/2026 4:00:00 AM)
Class Dismissed: Fothergill Fact-Checks Motion to Certify a Proposed Class Action Alleging Canadian Generic Drug Price Fixing Conspiracy
(2/20/2026 5:00:00 AM)
MONEY DOESN’T GROW ON TREES: Federal Court Dismisses GreenBlue’s Purported Expenses in Accounting of Profits Analysis
(1/28/2026 5:00:00 AM)
MAMMA MIA, LET THE CLAIM GO: Copyright Claim Respecting Queen Music Videos Struck with Leave to Amend
(1/14/2026 5:00:00 AM)
The High Price of Brand Piggybacking: Exxon Mobil Secures $275,000 Default Judgment in Trademark Battle
(12/17/2025 5:54:23 PM)
Why a Single Letter Can Cost You Your Brand: Fruiticana vs. Fruitocana
(12/17/2025 5:00:00 AM)
CONSTRUCTING A PROPER STATEMENT OF CLAIM: Federal Court Strikes Statement of Claim in The Construction Specifications Institute, Inc.
(11/26/2025 5:00:00 AM)
For The First Time In Canada, the Federal Court Finds Infringement by Common Design
(11/14/2025 6:48:22 PM)
Cards on the Table: Examining the Patentability of Poker Method Claims
(11/12/2025 5:00:00 AM)
Ontario Court Confirms Authority Over Challenges to AI Content Use
(11/7/2025 5:00:00 AM)
The Devil’s in the Details: Norwich Orders Denied Against Internet Service Providers
(10/31/2025 4:00:00 AM)